• About RedHill
  • Products
  • Partnering
  • Investors
  • News
  • Contact
  • Download Library

    Date Document Type

    Standards of Business Conduct and Ethics - Annex A

    RedHill Biopharma Corporate Presentation

    RedHill Biopharma BEKINDA Phase II Top-Line Results

    RHB-104 Phase III Crohn's Disease Program Update

    RedHill Biopharma Announces Successful Phase III Top-Line Results with BEKINDA for Acute Gastroenteritis

    RedHill Presentation (TALICIA) - Innovations in Gastroenterology 2017 Symposium

    RHB-104 Phase III Crohn's Disease Progress Update - Oct. 6 2016

    RedHill AGM - English

    RedHill AGM - Hebrew

    RedHill AGM - English